Comparison of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survey and American NHANES

Nephrology Dialysis Transplantation

Volumn 24, Issue 4, 2009, Pages 1220-1226

  Xu, Rong ^a   Zhang, Luxia ^a   Zhang, Puhong ^b   Wang, Fang ^a   Zuo, Li ^a   Wang, Haiyan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Centers for Preventive Medical Research   (China)

Author keywords

Albuminuria; Chronic kidney disease; Chronic renal insufficiency; Ethnicity

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; INSULIN;

ADULT; AFRICAN AMERICAN; ALBUMINURIA; ARTICLE; CAUCASIAN; CHINESE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CHINA; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; UNITED STATES;

EID: 65349189780     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn609     Document Type: Article

References (42)

1. Easterling RE. Racial factors in the incidence and causation of endstage renal disease (ESRD). Trans Am Soc Artif Intern Organs 1977; 23: 28-33
2. Freedman BI. End-stage renal failure in African Americans: insights in kidney disease susceptibility. Nephrol Dial Transplant 2002; 17: 198-200
3. Smith SR, Svetkey LP,DennisVW. Racial differences in the incidence and progression of renal diseases. Kidney Int 1991; 40: 815-822
4. Perneger TV,Whelton PK, Klag MJ.Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med 1995; 155: 1201-1208
5. Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis 1994; 23: 16-22
6. Stephens GW, Gillaspy JA, Clyne D et al. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis 1990; 15: 562-567
7. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988; 12: 285-290
8. Tarver-CarrME, Powe NR, Eberhardt MS et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 2002; 13: 2363-2370
9. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 1991; 5: 393-397
10. Hsu CY, Lin F, Vittinghoff E et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003; 14: 2902-2907
11. Young BA,KatonWJ,VonKorffMet al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol 2005; 16: 219-228
12. Lopes AA, Port FK. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, noninsulin- dependent diabetes, and end-stage renal disease. Am J Kidney Dis 1995; 25: 350-356
13. FreedmanBI, EspelandMA, Heise ERet al.Racial differences inHLA antigen frequency and hypertensive renal failure. Am J Hypertens1991; 4: 393-398
14. Pugh JA, Stern MP, Haffner SM et al. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol1988; 127: 135-144
15. Gonzales Villalpano CG, Stern MP, Arrendondo Perez B et al. Nephropathy in low income diabetics: The Mexico City Diabetes Study. Arch Med Res 1996; 27: 367-372
16. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-384
17. US Department of Health and Human Services; Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm
18. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) analytic guidelines. http://www.cdc.gov/nchs/about/ major/nhanes/nhanes2003- 2004/analytical-guidelines.htm.
19. http://www.cdc.gov/nchs/data/nhanes/frequency/lab18-doc.pdf.
20. http://www.cdc.gov/nchs/data/nhanes/nhanes-05-06/biopro-d.pdf.
21. http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l40-b-doc.pdf.
22. http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l40-c.pdf.
23. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944
24. Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem2007; 53: 766-772
25. Mattix HJ, Hsu CY, Shaykevich S et al. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002; 13: 1034-1039
26. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis2003; 41: 1-12
27. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
28. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 2000; 72: 1074-1081
29. Perloff D, Grim C, Flack J et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470
30. Mancia G, Grassi G. Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road?. J Am Soc Nephrol 2005; 16(Suppl 1): S74-S77
31. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation2002; 106: 3143-3421
32. Tozawa M, Iseki C, Tokashiki K et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007; 30: 937-943
33. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16: 952-958
34. Lee JE, Huh W, Son HJ et al. Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients. Nephron Clin Pract 2007; 106: c98-c103
35. Zhang L, Zuo L, Wang F et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc 2007; 82: 822-827
36. Hanevold CD, Pollock JS, Harshfield GA. Racial differences in microalbumin excretion in healthy adolescents. Hypertension 2008; 51: 334-338
37. Trachtenberg F, Barregard L. The effect of age, sex, and race on urinary markers of kidney damage in children.AmJ Kidney Dis 2007; 50: 938-945
38. O'Connor AS, Schelling JR. Diabetes and the kidney. Am J Kidney Dis 2005; 46: 766-773
39. Aloia JF, Vaswani A, Feuerman M et al. Differences in skeletal and muscle mass with aging in black and white women. Am J Physiol Endocrinol Metab 2000; 278: E1153-E1157
40. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002; 3: 141-146
41. United Committee of Constitution of Guidelines in Prevention and Treatment of Abnormality of Serum Lipid Spectrum for Chinese Adult. Guidelines in prevention and treatment of abnormality of serum lipid spectrum for Chinese adult. Chin J Cardiol 2007; 35: 390- 409
42. Mueller PW, MacNeil ML, Smith SJ et al. Interlaboratory comparison of the measurement of albumin in urine. Clin Chem 1991; 37: 191- 195